209 related articles for article (PubMed ID: 31319409)
1. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis.
Wang Y; Huang D; Xu WY; Wang YW; Che GW
Oncol Res Treat; 2019; 42(10):523-531. PubMed ID: 31319409
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
Jin J; Yang L; Liu D; Li WM
Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
[TBL] [Abstract][Full Text] [Related]
4. Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM; Lai CH; Chang HC; Chao TY; Tseng CC; Fang WF; Wang CC; Chung YH; Wang YH; Su MC; Huang KT; Chen HC; Chang YC; Lin MC
PLoS One; 2015; 10(8):e0136252. PubMed ID: 26313661
[TBL] [Abstract][Full Text] [Related]
5. The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors.
Liu N; Mao J; Tao P; Chi H; Jia W; Dong C
Medicine (Baltimore); 2022 Jan; 101(3):e28617. PubMed ID: 35060536
[TBL] [Abstract][Full Text] [Related]
6. Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer.
Sekine K; Kanda S; Goto Y; Horinouchi H; Fujiwara Y; Yamamoto N; Motoi N; Ohe Y
Lung Cancer; 2018 Oct; 124():179-188. PubMed ID: 30268458
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients.
Song YJ; Wang LX; Hong YQ; Lu ZH; Tong Q; Fang XZ; Tan J
Tumour Biol; 2016 Apr; 37(4):5285-93. PubMed ID: 26561466
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.
Xia H; Sun Z; Deng L; Zhu D; Wang D
Cancer Invest; 2016 Sep; 34(8):378-84. PubMed ID: 27558529
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.
Lee SF; Ng TY; Spika D
BMC Cancer; 2019 Apr; 19(1):338. PubMed ID: 30971203
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
Gu XB; Tian T; Tian XJ; Zhang XJ
Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
[TBL] [Abstract][Full Text] [Related]
11. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases.
Li A; Mu X; He K; Wang P; Wang D; Liu C; Yu J
Future Oncol; 2020 Oct; 16(30):2433-2444. PubMed ID: 32664750
[No Abstract] [Full Text] [Related]
13. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.
Hu P; Shen H; Wang G; Zhang P; Liu Q; Du J
PLoS One; 2014; 9(9):e108062. PubMed ID: 25275631
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
[TBL] [Abstract][Full Text] [Related]
17. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
Wang Y; Xu C; Zhang Z
BMC Med; 2023 Dec; 21(1):486. PubMed ID: 38053096
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis.
Hu RJ; Ma JY; Hu G
Clin Chim Acta; 2018 Jun; 481():142-146. PubMed ID: 29544747
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
